Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luxexcel is a pioneering technology company specializing in the 3D printing of prescription ophthalmic lenses. The company's proprietary VisionPlatform enables the manufacturing of high-quality, glass-like lenses without the need for traditional grinding or polishing, significantly reducing material waste and production steps. Luxexcel's technology is uniquely positioned to integrate smart technology into eyewear, allowing for the embedding of waveguides, electronics, and sensors directly into prescription lenses. In late 2022, the company was acquired by Meta to bolster its augmented reality (AR) hardware capabilities. Their solutions bridge the gap between high-tech smart eyewear and the necessity of vision correction for the general population. The company continues to operate as a key component of Meta's Reality Labs division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luxexcel.